NEOGRAN: traceable graph-text fusion for disease-protein relation prediction in biomedical knowledge graphs

Accurately predicting disease-protein relations in biomedical knowledge graphs helps link disease phenotypes to molecular mechanisms and supports disease-related knowledge discovery and candidate target identification. Biomedical knowledge graphs organize multisource biomedical knowledge, including diseases, proteins, drugs, and pathways, as entity nodes and relational edges, providing a structured foundation for modeling complex biomedical associations. Existing methods are often constrained by single-modality modeling, shallow graph-text fusion, and insufficient traceable evidence, which limits their ability to exploit graph-text complementarity and weakens downstream validation and structural evidence interpretation.

To address these limitations, we propose NEOGRAN, a graph-text collaborative framework comprising three core modules for relation prediction in biomedical knowledge graphs. The dual-encoder architecture captures graph structural patterns and biomedical entity representations to mitigate single-modality modeling. The bidirectional cross-attention module enables deep graph-text interaction to overcome shallow fusion. The interpretable path module generates traceable evidence paths to support prediction verification, structural evidence interpretation, and hypothesis generation. On PrimeKG, NEOGRAN achieved an AUPR of 0.9860 and an AUROC of 0.9875 under the 1:1 sampled classification setting, and further obtained an MRR of 0.0735 in the all-candidate ranking evaluation. External validation on BioKG further shows that NEOGRAN remains effective under differences in entity coverage, relation composition, and local topology, supporting its method-level generalizability across knowledge graph sources.

NEOGRAN provides an effective solution for relation prediction in biomedical knowledge graphs while offering traceable structural evidence for hypothesis generation and further biological validation.